CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-09 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −2,065 | $29.01 | $60K | 44,547 |
| 2024-01-09 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,443 | $29.01 | $158K | 160,475 |
| 2024-01-09 | Golden Lee Scott CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,225 | $29.01 | $36K | 37,914 |
| 2024-01-09 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,938 | $29.01 | $56K | 71,983 |
| 2024-01-09 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −1,521 | $29.01 | $44K | 61,820 |
| 2024-01-09 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −100 | $29.01 | $3K | 3,734 |
| 2024-01-08 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −1,188 | $28.64 | $34K | 37,499 |
| 2024-01-08 | SCHMERTZLER MICHAEL Director | Sale 10b5-1 | −1,500 | $27.81 | $42K | 115,266 |
| 2024-01-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −1,569 | $28.64 | $45K | 46,612 |
| 2024-01-08 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,237 | $28.64 | $64K | 165,918 |
| 2024-01-08 | Golden Lee Scott CHIEF MEDICAL OFFICER | Sale 10b5-1 | −775 | $28.64 | $22K | 39,139 |
| 2024-01-08 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,457 | $28.64 | $42K | 73,921 |
| 2024-01-08 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −1,236 | $28.64 | $35K | 63,341 |
| 2024-01-08 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −53 | $28.64 | $2K | 3,834 |
| 2024-01-05 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −10,107 | $27.15 | $274K | 168,155 |
| 2023-12-28 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award | +75,000 | 177,961 | ||
| 2023-12-12 | Gravier Pierre CHIEF FINANCIAL OFFICER | Purchase | +7,700 | $25.81 | $199K | 33,700 |
| 2023-09-06 | Young Alethia Director | Option exercise | +7,000 | $27.85 | $195K | 16,067 |
| 2023-09-06 | Young Alethia Director | Sale | −7,000 | $39.90 | $279K | 9,067 |
| 2023-09-06 | Young Alethia Director | Option exercise | +4,666 | $27.85 | $130K | 13,733 |
Page 36 of 41 · 804 trades